The road to HIV elimination
Celebrating Burnet excellence: Gust-McKenzie Medal and Frank Fenner Award
Lady Potter, Burnet Emerging Leader Fellowships
New international grants to fuel next-generation malaria vaccines
Research Reports + Policy Briefs
IMPACT Magazine
Events
Research Articles
How Science Matters Podcast
Study at Burnet
Exploring the Feasibility and Acceptability of Technological Interventions to Pr...
A systematic review and meta-analysis of heat exposure impacts on maternal, feta...
Mental Health Problems Among Indonesian Adolescents: Findings of a Cross-Section...
Stellabody®: A novel hexamer-promoting mutation for improved IgG potency
Vaccines
Diagnostics
Therapeutics
Antibody Platforms
Australia
Papua New Guinea
Myanmar
People of Burnet
Leadership
Burnet Partners
Board Members
Current Appeal
Monthly Giving
Trusts + Foundations
Corporate Supporters
Giving in Wills + Bequests
Supporter Stories
About Us
Careers
History
Annual + Financial Reports
Burnet Institute is developing biologic and small molecule therapeutics that have potential application in women's health, infectious disease & immunological conditions.
Find us at BIO 2024 this June.
In collaboration with Monash Institute of Pharmaceutical Sciences (MIPS), we are developing next-gen...
A small molecule therapeutic to potentially combat a variety of conditions affecting women’s sexual ...
A potentially broad spectrum Fc-fusion protein to treat SARS-CoV-2, comprising ACE2 (SARS-CoV-2 rece...